You are here

Nothing is easy when it comes to the ACA, ACOs, CMS

Dr. David Nash, Dean of the Jefferson School of Population Health, talks to P&T editor Sonja Sherritze about the state of healthcare in 2015 as the Supreme Court considers a second challenge to the Patient Protection and Affordable Care Act (ACA) and payers and providers struggle to meet the goals of their accountable care organizations (ACOs).

Dr. Nash recommends this article by the AMCP Task Force on Biosimilar Collective Intelligence Systems: Utilizing Data Consortia to Monitor Safety and Effectiveness of Biosimilars and Their Innovator Products.

March 2015 interview

More Headlines

BTC Is a Group of Rare Gastrointestinal Cancers With Limited Treatment Options, Poor Outcomes
Study Demonstrates Rapid Response in Patients, and Doesn’t Affect Tamoxifen Efficacy
Prescription App Can Serve As Training, Monitoring, and Reminder Tool
Resorbable Dextenza is the First Intracanalicular Insert for Drug Delivery
Patients with MS Suffered Stroke, Blood Vessel Tearing in Head and Neck After Receiving Drug
First Biosimilar For Adults With CD20-Positive, B-Cell Non-Hodgkin’s Lymphoma
Life-Threatening Side Effect of Drug for Acute Myeloid Leukemia
First Drug for Rare Autoimmune Disorder That Affects Nerve, Muscles Connection